Ken Griffin Bausch & Lomb Corp Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$13.68 - $17.6 $534,888 - $688,160	-39,100 Reduced 88.46%	5,100 $88,000
Q4 2023 Feb 14, 2024	SELL	$14.87 - $17.56 $755,396 - $892,047	-50,800 Reduced 53.47%	44,200 $754,000
Q3 2023 Nov 14, 2023	SELL	$16.8 - $20.99 $258,720 - $323,246	-15,400 Reduced 13.95%	95,000 $1.61 Million
Q2 2023 Aug 14, 2023	BUY	$16.03 - $20.07 $905,695 - $1.13 Million	56,500 Added 104.82%	110,400 $2.22 Million
Q1 2023 May 15, 2023	BUY	$15.67 - $18.91 $747,459 - $902,007	47,700 Added 769.35%	53,900 $938,000

Q4 2022 Feb 14, 2023	SELL	$13.66 - $16.04 $639,288 - $750,672	-46,800 Reduced 88.3%	6,200 $96,000
Q3 2022 Nov 14, 2022	SELL	$14.23 - $17.76 $707,231 - $882,672	-49,700 Reduced 48.39%	53,000 $813,000

37.6M

15.4K

127K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $5.08B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.